Data compiled by Redley Lamar · ChainSifter Intelligence
10Suppliers
8Customers
2Debt Items
8Related Chains
Source-Backed Evidence Depth
LivaNova PLC (LIVN) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
21Total relationships
2Distinct source URLs
12High confidence
0.766Average confidence
2026-09-13Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.
LivaNova PLC Suppliers
Ticker
Name
Confidence
Evidence
HAEMONETICS-CORPORATION
HAEMONETICS-CORPORATION
80%
LivaNova’s primary medical device competitors in the Cardiopulmonary and Neuromodulation product groups are Terumo Medical Corporation, Maquet Medical Systems, Medtronic plc, Haemonetics Corporation,…
MAQUET-MEDICAL-SYSTEMS
MAQUET-MEDICAL-SYSTEMS
80%
LivaNova’s primary medical device competitors in the Cardiopulmonary and Neuromodulation product groups are Terumo Medical Corporation, Maquet Medical Systems, Medtronic plc, Haemonetics Corporation,…
LivaNova’s primary medical device competitors in the Cardiopulmonary and Neuromodulation product groups are Terumo Medical Corporation, Maquet Medical Systems, Medtronic plc, Haemonetics Corporation,…
Reciprocal relationship from MDT graph: Reciprocal relationship from LIVN graph: Reciprocal relationship from MDT graph: Reciprocal relationship from LIVN graph: Reciprocal relationship from MDT grap…
NEUROPACE-INC
NEUROPACE-INC
80%
LivaNova’s primary medical device competitors in the Cardiopulmonary and Neuromodulation product groups are Terumo Medical Corporation, Maquet Medical Systems, Medtronic plc, Haemonetics Corporation,…
SPECTRUM-MEDICAL-LIMITED
SPECTRUM-MEDICAL-LIMITED
80%
LivaNova’s primary medical device competitors in the Cardiopulmonary and Neuromodulation product groups are Terumo Medical Corporation, Maquet Medical Systems, Medtronic plc, Haemonetics Corporation,…
TERUMO-MEDICAL-CORPORATION
TERUMO-MEDICAL-CORPORATION
80%
LivaNova’s primary medical device competitors in the Cardiopulmonary and Neuromodulation product groups are Terumo Medical Corporation, Maquet Medical Systems, Medtronic plc, Haemonetics Corporation,…
Reciprocal relationship from INSP graph: Reciprocal relationship from LIVN graph: Reciprocal relationship from INSP graph: Reciprocal relationship from LIVN graph: Reciprocal relationship from INSP g…
Reciprocal relationship from NPCE graph: Reciprocal relationship from LIVN graph: Reciprocal relationship from NPCE graph: Reciprocal relationship from LIVN graph: Reciprocal relationship from NPCE g…
Reciprocal relationship from NYXH graph: Reciprocal relationship from LIVN graph: Reciprocal relationship from NYXH graph: Reciprocal relationship from LIVN graph: Reciprocal relationship from NYXH g…
LivaNova PLC Customers
Ticker
Name
Confidence
Evidence
DISTRIBUTORS-AND-A-NON-GOVERNMENTAL-ORGANIZATION
DISTRIBUTORS-AND-A-NON-GOVERNMENTAL-ORGANIZATION
90%
Two of LivaNova’s non-U.S. subsidiaries currently sell medical devices, including cardiopulmonary and neuromodulation products, to distributors and a non-governmental organization in Iran to support …
IRANIAN-GOVERNMENT
IRANIAN-GOVERNMENT
80%
However, to the best of its knowledge at this time, LivaNova does not have any contracts or commercial arrangements with the Iranian government or other relevant entities.
Reciprocal relationship from INSP graph: coverage policies with all major national commercial payors. In terms of government program coverage, all seven MACs provide coverage of Inspire therapy when …
Reciprocal relationship from NPCE graph: rgery or are unwilling to undergo a destructive surgical procedure and we compete primarily with two manufacturers of neuromodulation devices for the treatmen…
BUSINESS-LIVANOVA-PLC
BUSINESS-LIVANOVA-PLC
62%
Item 1A. and elsewhere in this Report. The accompanying unaudited condensed consolidated financial statements of LivaNova and its consolidated subsidiaries have been prepared in accordance with U.S. …
CADENCE-NEUROSCIENCE-INC
CADENCE-NEUROSCIENCE-INC
62%
ring expense not allocated to segments. F-16 Note 5. Goodwill and Intangible Assets The following table presents LivaNova’s finite-lived and indefinite-lived intangible assets (in thousands): Decembe…
NOCTRIX-HEALTH-INC
NOCTRIX-HEALTH-INC
62%
ring expense not allocated to segments. F-16 Note 5. Goodwill and Intangible Assets The following table presents LivaNova’s finite-lived and indefinite-lived intangible assets (in thousands): Decembe…
RAINBOW-MEDICAL-LTD
RAINBOW-MEDICAL-LTD
62%
ring expense not allocated to segments. F-16 Note 5. Goodwill and Intangible Assets The following table presents LivaNova’s finite-lived and indefinite-lived intangible assets (in thousands): Decembe…
LivaNova PLC Debt Obligations
Instrument
Description
Confidence
Evidence
LIVN-DEBT-10727
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2013-04-26.
LIVN-DEBT
Debt stack $293.5M
90%
Market cache reports total debt of $293.5M.
LivaNova PLC Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for LivaNova PLC.
LivaNova PLC Ownership
Holder
Name
Confidence
Evidence
LIVN-OWNER-BARCLAYS-PLC
BARCLAYS PLC
90%
13F overlay lists BARCLAYS PLC as top holder; 297 tracked holders.
